In malignant ovarian cancer, changes in SELENBP1 expression are useful indicators of abnormal selenium/androgen pathways, and such changes may reveal prognostic information relating to ovarian cancer (Huang et al. 2006). This evidence concerns the gene SELENBP1 and ovarian cancer.